Antares Pharma Beats Suit Over 'Vague' Drug Statements
Antares Pharma Inc. again defeated a proposed securities class action alleging it misled investors about the risks of hypertension, suicide and depression associated with a testosterone medication after a New Jersey...To view the full article, register now.
Already a subscriber? Click here to view full article